期刊文献+

认知行为疗法用于抗精神病药物所致体重增加的Meta分析 被引量:1

Cognitive Behavioral Therapy for Antipsychotics-induced Weight Gain: A Meta-analysis
原文传递
导出
摘要 目的系统评价认知行为疗法用于治疗抗精神病药物所致体重增加的效果。方法计算机检索2000年1月-2012年12月MEDLINE、Cochrane图书馆、中国学术期刊全文数据库(CNKI)、中文科技期刊全文数据库(VIP)、万方数据库,收集关于认知行为疗法治疗抗精神病药物所致体重增加的随机对照试验。由两名研究者独立进行文献筛选、资料提取和文献质量评价,采用RevMan5.0软件对资料进行Meta分析。结果最终纳入6篇随机对照研究,包括295名受试者。结果显示,治疗结束时研究组体重低于对照组[WMD=-1.83 Kg,95%CI(-2.79,-0.88)Kg],差异有统计学意义(P<0.01),治疗结束时研究组体重指数低于对照组[WMD=-0.69 Kg/m2,95%CI(-1.04,-0.34)Kg/m2],差异有统计学意义(P<0.01)。结论现有的研究显示,认知行为疗法能够改善抗精神病药物所致体重增加。 Objective To assess whether cognitive behavioral therapy prevents body weight gain in persons with serious mental ill -ness who are treated with antipsychotics .Methods The randomized controlled trials ( RCT) about cognitive behavioral therapy for pre-vention of weight gain with antipsychotics from January 2000 to December 2012 were selected in the Medline,Cochrane Library,CNKI, VIP and Wanfang Data .Two reviewers independently screened the literatures ,extracted the data ,and evaluated the methodological quali-ty.The meta-analyses were conducted by using RevMan 5.0 software.Results The total 6 RCTs were selected and 295 patients were involved .The results of meta-analyses showed that the efficacy of the cognitive behavioral group was superior to that of the control group in lessen body mass[WMD=-1.83 Kg,95%CI(-2.79,-0.88)Kg,(P〈0.01)],BWI[WMD=-0.69 Kg/m2,95%CI(-1.04,-0.34) Kg/m2(P〈0.01)]with significant differences.Conclusion Cognitive behavioral therapy is effective in attenuating antipsychotics -in-duced weight gain .
出处 《中国健康心理学杂志》 2014年第11期1605-1607,共3页 China Journal of Health Psychology
关键词 META分析 认知行为 抗精神病药物 体重 Meta-analysis Cognitive behavior Antipsychotics Weight
  • 相关文献

参考文献17

  • 1Leucht S,Corves C,Arbter D,et al.Second-generation versus firstgeneration antipsychotic drugs for schizophrenia:A meta-analysis[J].The Lancet,2009,373(9657):31-41.
  • 2Correll C U,Sheridan E M,DelBello M P.Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania:A comparative analysis of acute,randomized,placebo‐controlled trials[J].Bipolar Disorders,2010,12(2):116-141.
  • 3Correll C U,Kratochvil C J,March J S.Developments in pediatric psychopharmacology:Focus on stimulants,antidepressants,and antipsychotics[J].The Journal of Clinical Psychiatry,2011,72(5):655-670.
  • 4De Hert M,Detraux J,van Winkel R,et al.Metabolic and cardiovascular adverse effects associated with antipsychotic drugs[J].Nature Reviews Endocrinology,2012,8(2):114-126.
  • 5Maayan L,Vakhrusheva J,Correll C U.Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities:A systematic review and meta-analysis[J].Neuropsychopharmacology,2010,35(7):1520-1530.
  • 6Narula P K,Rehan H S,Unni K E S,et al.Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia:A double-blind,placebo-controlled trial[J].Schizophrenia Research,2010,118(1):218-223.
  • 7Khazaal Y,Fresard E,Rabia S,et al.Cognitive behavioural therapy for weight gain associated with antipsychotic drugs[J].Schizophrenia Research,2007,91(1):169-177.
  • 8Alvarez-Jimenez M,Gonzalez-Blanch C,Vazquez-Barquero J L,et al.Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients:A randomized controlled trial[J].The Journal of Clinical Psychiatry,2006,67(8):1253-1260.
  • 9Brar J S,Ganguli R,Pandina G,et al.Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder[J].Journal of Clinical Psychiatry,2005,66(2):205-212.
  • 10Kwon J S,Choi J S,Bahk W M,et al.Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder:A 12-week randomized controlled clinical trial[J].The Journal of Clinical Psychiatry,2006,67(4):547-553.

二级参考文献34

  • 1任显峰,郑素娟,付兴娟,马照红.阿米替林合并认知疗法治疗精神分裂症后抑郁的对照研究[J].上海精神医学,2004,16(2):83-85. 被引量:4
  • 2徐子燕,杨清艳,李占江.精神分裂症的认知行为治疗[J].中国健康心理学杂志,2006,14(3):352-354. 被引量:24
  • 3中华医学会精神科分会编.中国精神障碍分类与诊断标准[M].3版.济南:山东科学出版社,2001:31-56.
  • 4Aydemir O,Esen Danaci A,Pirildar S.Distinguishing depressivefrom nondepressive patients in schizophrenia interms of symptom a-tologyp[J].Turk Psikiyatri Derg,2002,13:173-175.
  • 5Siris S G,Addington D,Azorin J M.Depression in schizophrenia:Recognition and management in the USA[J].SR,2001,47:185-190.
  • 6De Hert M, Detraux J, van Winkel R, et al. Metabolic and cardiovascu- lar adverse effects associated with antipsychotic drugs [ J ]. Nature Re- views Endocrinology ,2011,8 ( 2 ) : 114-126.
  • 7Maayan L, Vakhrusheva J, Correll C U. Effectiveness of medications used to attenuate antipsychotic - related weight gain and metabolic ab- normalities : A systematic review and meta - analysis [ J ]. Neuropsycho- pharmacology ,2010,35 ( 7 ) : 1590-1530.
  • 8Wu R R, Jin H, Gao K, et al. Metformin for treatment of antipsychotic - induced amenorrhea and weight gain in women with first - episode schizophrenia: A, double - blind, randomized, placebo - controlled study [ J ]. American Journal of Psychiatry,2012,169 ( 8 ) :813-821.
  • 9Baptista T, Martinez J, Lacruz A, et al. Metformin for prevention of weight gain and insulin resistance with olanzapine : A double - blind placebo - controlled trial [ J ]. Can J Psychiatry,2006,51 ( 8 ) : 192-196.
  • 10Baptista T, Rangel N, Ferndndez V, et al. Mefformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration : A multicentric, double - blind, placebo - controlled trial[ J]. Schizophrenia research,2007,93 (1) :99-108.

共引文献35

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部